Stimuli-Responsive Supramolecular Biomaterials for Cancer Theranostics

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• Cancer theranostics aims to deliver imaging and therapeutic agents to tumors precisely.
• Current "smart" systems require enhanced spatial, temporal, and dosage control.
• Supramolecular interactions enable the design of advanced biomaterials for controlled drug delivery.

Purpose of the Study:

• To review recent advances in intelligent supramolecular biomaterials for cancer theranostics.
• To highlight the spatiotemporal control mechanisms of these biomaterials.
• To discuss challenges and future perspectives for clinical translation.

Main Methods:

• Exploiting endogenous and exogenous stimuli for biomaterial response.
• Designing supramolecular biomaterials with dynamic, reversible features.
• Focusing on ordered architectures, tailored morphologies, and multiple cargo loading.

Main Results:

• Supramolecular biomaterials demonstrate potential for optimized therapeutic efficacy.
• These materials can minimize systemic adverse effects in oncology.
• Stimuli-responsive morphological transformations are key to their function.

Conclusions:

• Intelligent supramolecular biomaterials are promising for advanced cancer theranostics.
• Spatiotemporal control is crucial for their effective application.
• Further research is needed to overcome clinical translation challenges.